Should diagnostic testing for Clostridioides difficile infection be performed in a patient with unexplained new‑onset diarrhea who has had three or more unformed stools in the past 24 hours?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnostic Testing for C. difficile Should Be Performed in Patients with ≥3 Unformed Stools in 24 Hours

The correct answer is B) Unexplained and new-onset diarrhea with ≥ 3 unformed stools in the past 24 hours.

The 2018 IDSA/SHEA guidelines explicitly state that patients with unexplained and new-onset ≥3 unformed stools in 24 hours are the preferred target population for testing for CDI 1. This represents the current standard of care for determining when to order C. difficile testing.

Why This Threshold Matters

The ≥3 unformed stools criterion is not arbitrary—it balances sensitivity for detecting clinically significant disease against the risk of overdiagnosis. Testing patients who don't meet this threshold leads to:

  • Overdiagnosis of colonization rather than true infection (particularly with highly sensitive NAAT testing) 2
  • Unnecessary antibiotic treatment with associated risks of resistance and adverse effects
  • Increased healthcare costs and inappropriate isolation precautions 3

The evidence base shows that clinical criteria for CDI diagnosis have evolved over 40 years, with the threshold progressively decreasing from >5 loose stools per day (1974) to the current ≥3 unformed stools in 24 hours (2013) 1. This modern definition represents the optimal balance between diagnostic sensitivity and clinical relevance.

Critical Exclusions Before Testing

Do not test patients who:

  • Have received laxatives within the previous 48 hours 1
  • Are asymptomatic (except for epidemiological studies) 1
  • Are infants ≤12 months of age (high asymptomatic carriage rates) 1

Testing should only proceed if diarrhea is unexplained—meaning not clearly attributable to underlying conditions like inflammatory bowel disease, enteral tube feeding, intensive chemotherapy, or laxative use 1. However, these conditions themselves increase CDI risk, so if symptoms persist after stopping potentially causative therapies, testing becomes appropriate 1.

Why Other Options Are Incorrect

Option A (≥1 unformed stool): This threshold is far too sensitive and would result in massive overdiagnosis. Studies show that 36-39% of patients tested for CDI don't even meet the minimal ≥3 stool criterion, yet they're already being overtested 1.

Options C and D (constipation patterns): These do not represent typical CDI presentations. CDI characteristically causes diarrhea, not constipation. Testing for constipation would be inappropriate and not supported by any guideline recommendations.

Common Pitfalls to Avoid

  1. Testing formed stools: Laboratories should reject specimens that are not liquid or soft (don't take the shape of the container) 1

  2. Repeat testing within 7 days: Do not perform repeat testing during the same diarrheal episode—this only increases false positives from colonization 1

  3. Test of cure: Never test asymptomatic patients after treatment to verify cure 4

  4. Testing without clinical context: The positive predictive value of even highly sensitive tests depends on pretest probability. Inappropriate testing in low-probability patients yields more false positives than true positives 2

The guideline recommendation is weak due to very low quality of evidence 1, but the ≥3 unformed stools threshold represents expert consensus based on decades of clinical experience and remains the standard for optimizing diagnostic yield while minimizing overdiagnosis 5, 6, 4.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.